Market Chatter: AbbVie in Talks to Acquire Psychedelics Maker Gilgamesh Pharmaceuticals in $1 Billion Deal-February 2024-www.financetom.com

Market Chatter: AbbVie in Talks to Acquire Psychedelics Maker Gilgamesh Pharmaceuticals in $1 Billion Deal

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Market Chatter: AbbVie in Talks to Acquire Psychedelics Maker Gilgamesh Pharmaceuticals in $1 Billion Deal

Jul 31, 2025 12:06 PM

02:45 PM EDT, 07/31/2025 (MT Newswires) -- AbbVie ( ABBV ) is in talks to acquire Gilgamesh Pharmaceuticals in a deal that could value the psychedelics developer at about $1 billion, Bloomberg reported Thursday, citing people familiar with the matter.

The potential deal comes a year after AbbVie ( ABBV ) and Gilgamesh entered into a collaboration to develop next-generation psychedelics for mental health conditions, according to the report.

An announcement could be made in the coming weeks, Bloomberg said, adding that deliberations are ongoing and could be delayed or fall apart.

AbbVie ( ABBV ) did not immediately respond to MT Newswires' request for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 189.12, Change: -0.19, Percent Change: -0.10

Previous page： Nexalin Shares Fall After Pricing of $5 Million Public Offering Next page： Sotera Health 'Is Uniquely Insulated From Potential Tariff Policy,' Goldman Sachs Says

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Nexalin Shares Fall After Pricing of $5 Million Public Offering

May 26, 2025

02:21 PM EDT, 05/05/2025 (MT Newswires) -- Nexalin Technology ( NXL ) shares fell over 23% in recent trading Monday after the company priced its underwritten public offering of 3.85 million shares at $1.30 per share. The stock closed at $1.79 Friday. Nexalin ( NXL ) said it has granted its underwriters a 45-day option to purchase up to 577,500...

Sotera Health 'Is Uniquely Insulated From Potential Tariff Policy,' Goldman Sachs Says

May 26, 2025

Last week, Sotera Health Co ( SHC ) reported adjusted earnings per share of 14 cents, up from 13 cents a year ago, beating the consensus of 12 cents. The sterilization solutions and lab testing and advisory services provider reported sales of $254.52 million, up 2.6% year over year (+4.4% at constant currency), beating the consensus of $245.79 million. Also...

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

NAPCO Security Technologies Shares Rise After Fiscal Q3 Beat, Dividend Boost, CFO Appointment

May 26, 2025

02:00 PM EDT, 05/05/2025 (MT Newswires) -- NAPCO Security Technologies ( NSSC ) shares rose over 7% in recent Monday trading after the company reported fiscal Q3 results that beat consensus and announced a higher quarterly dividend and a new chief financial officer. The company reported fiscal Q3 earnings of $0.28 per diluted share, down from $0.36 a year earlier....